« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 10
, Pages 947-954
, October 2009
Inflammation and Thrombosis Biomarkers and Incident Frailty in Postmenopausal Women
References
- Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146–M156
- Frailty: emergence and consequences in women ages 65 and older in The Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005;53:1321–1330
- Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001
- . Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180–187
- Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162:2333–2341
- Serum IL-6 and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639–646
- Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002;50:1947–1954
- Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52:1105–1113
- Inflammation and frailty in older women. J Am Geriatr Soc. 2007;55:864–871
- . T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc. 2008;56:904–908
- The physical and biological characterization of a frail mouse model. J Gerontol A Biol Sci Med Sci. 2008;63:391–398
- Frailty and risk of venous thromboembolism in older adults. J Gerontol A Biol Sci Med Sci. 2007;62:79–82
- Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med. 2007;167:635–641
- The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13(9 suppl):S107–S121
- . Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 1998;19:61–109
- . The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2:217–227
- . Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview. Psychiatry Res. 2001;103:261–270
- . The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401
- . Hemostasis factors and aging. Exp Gerontol. 2008;43:66–73
- Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost. 2006;4:982–987
- Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101:1243–1248
- Tissue plasminogen activator antigen and coronary heart disease (Prospective study and meta-analysis). Eur Heart J. 2004;25:252–259
- Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001;103:2323–2327
- Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56:M158–M166
- . A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res. 2007;120:819–847
- Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci Med Sci. 2006;61:963–969
- Spousal caregivers of patients with Alzheimer's disease show longitudinal increases in plasma level of tissue-type plasminogen activator antigen. Psychosom Med. 2007;69:816–822
- Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci U S A. 2004;101:16345–16350
- . Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583:174–185
Funding: The Women's Health Initiative program is funded by the National Heart, Lung, and Blood Institute, US Department of Health and Human Services. A full listing of Women's Health Initiative investigators can be found at http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf. This article was supported by grant R01 AG025441 to Dr LaCroix from the National Institute of Aging.
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(09)00539-7
doi: 10.1016/j.amjmed.2009.04.016
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 10
, Pages 947-954
, October 2009

